Resistance to trastuzumab in HER2-positive mucinous invasive ductal breast carcinoma.
Resistance to trastuzumab in HER2-positive mucinous invasive ductal breast carcinoma. Clin Breast Cancer. 2013 Apr; 13(2):156-8.
-
Adenocarcinoma, Mucinous
-
Adult
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Biomarkers, Tumor
-
Breast Neoplasms
-
Carcinoma, Ductal, Breast
-
Drug Resistance, Neoplasm
-
Female
-
Humans
-
Immunoenzyme Techniques
-
Middle Aged
-
Neoplasm Grading
-
Neoplasm Staging
-
Prognosis
-
Receptor, ErbB-2
-
Receptors, Estrogen
-
Receptors, Progesterone
-
Trastuzumab